Li Li

机构：Fujian Medical University, The University of Texas MD Anderson Cancer Center, Army Medical University, Shanghai Jiao Tong University, The Affiliated Yongchuan Hospital of Chongqing Medical University, Southwest Hospital, Fujian Provincial Hospital, Chongqing Medical University · ORCID：0000-0002-6680-5886

发表论文 181 篇 · 总被引 4307 次 · h-index 33

代表论文

• Characterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux (2023 · Nature Communications · 被引 98)
• Combined inflammatory parameters and tertiary lymphoid structure predict prognosis in patients with resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy (2023 · Frontiers in Immunology · 被引 31)
• Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era (2023 · Experimental Hematology and Oncology · 被引 24)
• First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1 (2023 · International Journal of Clinical Oncology · 被引 13)
• Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition with Quizartinib and Milademetan in FLT3 -ITD Mutant/ TP53 Wild-type Acute Myeloid Leukemias (2025 · Clinical Cancer Research · 被引 7)
• Somatic TP53 Mutations Drive T and NK Cell Dysfunction in AML and Can be Rescued by Reactivating Wild Type p53 (2025 · medRxiv · 被引 5)